{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:41:53Z","timestamp":1777347713988,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2334-12-276","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T17:14:16Z","timestamp":1351703656000},"source":"Crossref","is-referenced-by-count":10,"title":["Does limited virucidal activity of biocides include duck hepatitis B virucidal action?"],"prefix":"10.1186","volume":"12","author":[{"given":"Andreas","family":"Sauerbrei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schacke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Gl\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Bust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger F","family":"Rabenau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wutzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,30]]},"reference":[{"key":"2052_CR1","first-page":"261","volume":"29","author":"Robert Koch-Institut","year":"2011","unstructured":"Robert Koch-Institut: Zur Situation bei wichtigen Infektionskrankheiten in Deutschland. Virushepatitis B, C und D im Jahr 2010. Epidemiol Bull. 2011, 29: 261-274.","journal-title":"Epidemiol Bull"},{"key":"2052_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1067\/mic.2001.114233","volume":"29","author":"SA Sattar","year":"2001","unstructured":"Sattar SA, Treto J, Springthorpe VS, Giulivi A: Preventing the spread of hepatitis B and C viruses: where are germicides relevant?. Am J Infect Control. 2001, 29: 187-197. 10.1067\/mic.2001.114233.","journal-title":"Am J Infect Control"},{"key":"2052_CR3","volume-title":"Chemical disinfectants and antiseptics. Virucidal quantitative suspension test for chemical disinfectants and antiseptics used in human medicine. Test method and requirements (phase 2, Step 1)","author":"EN 14476","year":"2007","unstructured":"EN 14476: Chemical disinfectants and antiseptics. Virucidal quantitative suspension test for chemical disinfectants and antiseptics used in human medicine. Test method and requirements (phase 2, Step 1). 2007, Beuth, Berlin, Wien, Z\u00fcrich"},{"key":"2052_CR4","first-page":"303","volume":"18","author":"WD J\u00fclich","year":"1993","unstructured":"J\u00fclich WD, von Rheinbaben F, Steinmann J, Kramer A: On the virucidal efficacy of chemical and physical disinfectants or disinfection procedures. Hyg Med. 1993, 18: 303-326.","journal-title":"Hyg Med"},{"key":"2052_CR5","first-page":"293","volume":"34","author":"J Bl\u00fcmel","year":"2009","unstructured":"Bl\u00fcmel J, Glebe D, Neumann-Haefelin D, Rabenau HF, Rapp I, von Rheinbaben F, Ruf B, Sauerbrei A, Schwebke I, Steinmann J, Willkommen H, Wolff MH, Wutzler P: Guideline of \u201cDeutsche Vereinigung zur Bek\u00e4mpfung der Viruskrankheiten e.V.\u201d (DVV; German Association for the Control of Virus Diseases) and Robert Koch-Institute (RKI; German Federal Health Authority) for testing the virucidal efficacy of chemical disinfectants in the human medical area. Hyg Med. 2009, 34: 293-299.","journal-title":"Hyg Med"},{"key":"2052_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1471-2334-10-185","volume":"10","author":"HF Rabenau","year":"2010","unstructured":"Rabenau HF, Rapp I, Steinmann J: Can vaccinia virus be replaced by MVA virus for testing virucidal activity of chemical disinfectants?. BMC Infect Dis. 2010, 10: 185-10.1186\/1471-2334-10-185.","journal-title":"BMC Infect Dis"},{"key":"2052_CR7","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1128\/JCM.31.12.3296-3304.1993","volume":"31","author":"DL Prince","year":"1993","unstructured":"Prince DL, Prince N, Thraenhart O, Muchmore E, Bonder E, Pugh J: Methodological approaches to disinfection of human hepatitis B virus. J Clin Microbiol. 1993, 31: 3296-3304.","journal-title":"J Clin Microbiol"},{"key":"2052_CR8","first-page":"112","volume-title":"PDE\/EMEA European virus safety forum Vol. 118","author":"WH Gerlich","year":"2004","unstructured":"Gerlich WH, Glebe D: Methods for validation of hepatitis B virus inactivation. PDE\/EMEA European virus safety forum Vol. 118. Edited by: Robertson J. 2004, Karger, Basel Dev Biol, 112-122."},{"key":"2052_CR9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1046\/j.1537-2995.1997.37997454021.x","volume":"37","author":"J Hilfenhaus","year":"1997","unstructured":"Hilfenhaus J, Groner A, Nowak T, Weimer T: Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses. Transfusion. 1997, 37: 935-940. 10.1046\/j.1537-2995.1997.37997454021.x.","journal-title":"Transfusion"},{"key":"2052_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0166-0934(83)90003-4","volume":"7","author":"CR Howard","year":"1983","unstructured":"Howard CR, Dixon J, Young P, van Eerd P, Schellekens H: Chemical inactivation of hepatitis B virus: the effect of disinfectants on virus-associated DNA polymerase activity, morphology and infectivity. J Virol Methods. 1983, 7: 135-148. 10.1016\/0166-0934(83)90003-4.","journal-title":"J Virol Methods"},{"key":"2052_CR11","first-page":"1","volume":"176","author":"G Fr\u00f6sner","year":"1982","unstructured":"Fr\u00f6sner G, Jentsch G, Uthemann H: Destroying of antigenicity and influencing the immunochemical reactivity of hepatitis B virus antigens (HbsAg, HbcAg and HbeAG) through disinfectants \u2013 a proposed method for testing. Zentralbl Bakteriol Mikrobiol Hyg [B]. 1982, 176: 1-14.","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg [B]"},{"key":"2052_CR12","first-page":"472","volume":"176","author":"O Thraenhart","year":"1982","unstructured":"Thraenhart O, Kuwert EK, Scheiermann N, Dermietzel R, Paar D, Maruhn D, Alberti A, Richter HJ, Hotz J: Comparison of the morphological alteration and disintegration test (MADT) and the chimpanzee infectivity test for determination of hepatitis B virucidal activity of chemical disinfectants. Zentralbl Bakteriol Mikrobiol Hyg [B]. 1982, 176: 472-484.","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg [B]"},{"key":"2052_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1053\/jhin.2001.0945","volume":"47","author":"C Payan","year":"2001","unstructured":"Payan C, Cottin J, Lemarie C, Ramont C: Inactivation of hepatitis B virus in plasma by hospital in-use chemical disinfectants assessed by a modified HepG2 cell culture. J Hosp Infect. 2001, 47: 282-287. 10.1053\/jhin.2001.0945.","journal-title":"J Hosp Infect"},{"key":"2052_CR14","doi-asserted-by":"publisher","first-page":"15655","DOI":"10.1073\/pnas.232137699","volume":"99","author":"P Gripon","year":"2002","unstructured":"Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C: Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci USA. 2002, 99: 15655-15660. 10.1073\/pnas.232137699.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2052_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0092-8674(86)90602-1","volume":"47","author":"JS Tuttleman","year":"1986","unstructured":"Tuttleman JS, Pourcel C, Summers J: Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell. 1986, 47: 451-460. 10.1016\/0092-8674(86)90602-1.","journal-title":"Cell"},{"key":"2052_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/hep.1840070418","volume":"7","author":"PL Marion","year":"1987","unstructured":"Marion PL, Cullen JM, Azcarraga RR, Van Davelaar MJ, Robinson WS: Experimental transmission of duck hepatitis B virus to Pekin ducks and to domestic geese. Hepatology. 1987, 7: 724-731. 10.1002\/hep.1840070418.","journal-title":"Hepatology"},{"key":"2052_CR17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1128\/JVI.36.3.829-836.1980","volume":"36","author":"WS Mason","year":"1980","unstructured":"Mason WS, Seal G, Summers J: Virus of Pekin ducks with structure and biological relatedness to human hepatitis B virus. J Virol. 1980, 36: 829-836.","journal-title":"J Virol"},{"key":"2052_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jviromet.2005.05.025","volume":"129","author":"A Sauerbrei","year":"2005","unstructured":"Sauerbrei A, Schacke M, Schultz U, Egerer R, Merkle I, Glebe D, Gerlich W, Wutzler P: Alternative methods for validation of cell culture infection with duck hepatitis B virus. J Virol Methods. 2005, 129: 178-185. 10.1016\/j.jviromet.2005.05.025.","journal-title":"J Virol Methods"},{"key":"2052_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jhin.2006.04.013","volume":"64","author":"Sauerbrei","year":"2006","unstructured":"Sauerbrei , Schacke M, Gl\u00fcck B, Egerer R, Wutzler P: Validation of biocides against duck hepatitis B virus as a surrogate virus for the human hepatitis B virus. J Hosp Infect. 2006, 64: 358-365. 10.1016\/j.jhin.2006.04.013.","journal-title":"J Hosp Infect"},{"key":"2052_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jviromet.2008.12.004","volume":"157","author":"M Schacke","year":"2009","unstructured":"Schacke M, Gl\u00fcck B, Wutzler P, Sauerbrei A: In vitro cultivation and cryopreservation of duck embryonic hepatocytes. J Virol Methods. 2009, 157: 25-31. 10.1016\/j.jviromet.2008.12.004.","journal-title":"J Virol Methods"},{"key":"2052_CR21","volume-title":"Animals and alternatives in toxicity testing","author":"M Bolls","year":"1983","unstructured":"Bolls M, Ridell RJ, Worden AN: Animals and alternatives in toxicity testing. 1983, Academic, London, New York"},{"key":"2052_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00430-001-0103-0","volume":"190","author":"CA Jursch","year":"2002","unstructured":"Jursch CA, Gerlich WH, Glebe D, Schaefer S, Marie O, Thraenhart O: Molecular approaches to validate disinfectants against human hepatitis B virus. Med Microbiol Immunol. 2002, 190: 189-197. 10.1007\/s00430-001-0103-0.","journal-title":"Med Microbiol Immunol"},{"key":"2052_CR23","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jhin.2003.12.031","volume":"56","author":"C Payan","year":"2004","unstructured":"Payan C, Pivert A, Kampf G, Ramont C, Cottin J, Lemarie C: Assessment of new chemical disinfectants for HBV virucidal activity in a cell culture model. J Hosp Infect. 2004, 56: S58-S63.","journal-title":"J Hosp Infect"},{"key":"2052_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00103-003-0754-7","volume":"47","author":"Anonymous","year":"2004","unstructured":"Anonymous: Pr\u00fcfung und Deklaration der Wirksamkeit von Desinfektionsmitteln gegen Viren. Stellungnahme des Arbeitskreises Viruzidie beim Robert Koch-Institut (RKI) sowie des Fachausschusses \u201cVirusdesinfektion\u201d der Deutschen Gesellschaft zur Bek\u00e4mpfung der Viruskrankheiten (DVV) und der Desinfektionsmittelkommission der Deutschen Gesellschaft f\u00fcr Hygiene und Mikrobiologie (DGHM). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2004, 47: 62-66.","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"2052_CR25","volume-title":"Environmental Protection Agency. Protocol for testing the efficacy of disinfectants used to inactivate duck hepatitis B virus and to support corresponding label claims","author":"U.S","year":"2000","unstructured":"U.S: Environmental Protection Agency. Protocol for testing the efficacy of disinfectants used to inactivate duck hepatitis B virus and to support corresponding label claims. 2000, MicroBioTest, Inc, Gent"},{"key":"2052_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1017\/S0950268800067480","volume":"106","author":"SM Murray","year":"1991","unstructured":"Murray SM, Freiman JS, Vickery K, Lim D, Cossart YE, Whiteley RK: Duck hepatitis B virus: a model to assess efficacy of disinfectants against hepadnavirus infectivity. Epidemiol Infect. 1991, 106: 435-443. 10.1017\/S0950268800067480.","journal-title":"Epidemiol Infect"},{"key":"2052_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0741-5214(99)70138-2","volume":"30","author":"X Chaufour","year":"1999","unstructured":"Chaufour X, Deva AK, Vickery K, Zou J, Kumaradeva P, White GH, Cossart YE: Evaluation of disinfection and sterilization of reusable angioscopes with the duck hepatitis B model. J Vasc Surg. 1999, 30: 277-282. 10.1016\/S0741-5214(99)70138-2.","journal-title":"J Vasc Surg"},{"key":"2052_CR28","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0196-6553(99)70064-7","volume":"27","author":"JC Pugh","year":"1999","unstructured":"Pugh JC, Ijaz MK, Suchmann DB: Use of surrogate models for testing efficacy of disinfectants against hepatitis B virus. Am J Infect Control. 1999, 27: 375-376. 10.1016\/S0196-6553(99)70064-7.","journal-title":"Am J Infect Control"},{"key":"2052_CR29","first-page":"158","volume":"51","author":"A Sauerbrei","year":"2010","unstructured":"Sauerbrei A, Wutzler P: Virucidal efficacy of PVP-iodine-containing disinfectants. Lett Appl Microbiol. 2010, 51: 158-163.","journal-title":"Lett Appl Microbiol"},{"key":"2052_CR30","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.jhin.2003.12.030","volume":"56","author":"J Steinmann","year":"2004","unstructured":"Steinmann J: Surrogate viruses for testing virucidal efficacy of chemical disinfectants. J Hosp Infect. 2004, 56: S49-S54.","journal-title":"J Hosp Infect"},{"key":"2052_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2334-7-5","volume":"7","author":"G Kampf","year":"2007","unstructured":"Kampf G, Steinmann J, Rabenau H: Suitability of vaccinia virus and bovine viral diarrhea virus (BVDV) for determining activities of three commonly-used alcohol-based hand rubs against enveloped viruses. BMC Infect Dis. 2007, 7: 5-10.1186\/1471-2334-7-5.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-276\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T09:58:14Z","timestamp":1594807094000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,30]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2052"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-276","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,30]]},"article-number":"276"}}